DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Wynn D, Kaufman M, Montalban X et al.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Lancet Neurol 2010;
9: 381-390
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.